Drug data last refreshed 4h ago · AI intelligence enriched 1w ago
Nitrous oxide (N₂O) is an inhalational gas anesthetic and analgesic agent approved as a USP pharmaceutical product by Advanced Solutions Life Sciences. It is used primarily for anesthesia and analgesia in surgical and dental procedures, as well as in certain acute pain and sedation settings. The drug works through central nervous system depression via multiple receptor pathways including NMDA antagonism.
Product is at peak commercial maturity with moderate competitive pressure (30%), suggesting stable but not rapidly expanding team requirements.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Nitrous Oxide Prior to Intranasal Midazolam for Moderate Dental Sedation in Pediatric Patients
Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus (NO FEAR-BE)
A Comparison of Intranasal Midazolam and Nitrous Oxide (N2O) Minimal Sedation for Minor Procedures in a Pediatric Emergency Department
Nitrous Oxide Versus Intravenous Sedation for Anesthesia
Nitrous Oxide for Pain Management During In-office Transcervical Sterilization
Worked on NITROUS OXIDE, USP at Advanced Solutions Life Sciences? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Advanced Solutions Life Sciences is hiring 1 role related to this product
This product currently supports very limited career opportunities, with only one linked job (Test Technician in IT), suggesting a small, specialized team footprint. Career progression on this product would likely be constrained by its mature lifecycle and commodity-market position.
1 open roles linked to this drug